Thesis by Li, Pan
![[up]](/style/images/multi_up.png)
Up a levelNumber of items: 2.
Li, Pan (2022): Belizatinib is a potent inhibitor for non-small cell lung cancers driven by different variants of EML4-ALK fusion proteins carrying L1196M-mutations. Dissertation, LMU München: Faculty of Medicine
Li, Pan (2017): Der Einfluss von Ki67-index, Tumorlokalisation, Alter und Mismatch-Reparatur-Status auf das Überleben von Patienten mit Kolorektalkarzinom. Dissertation, LMU München: Faculty of Medicine